Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine plus temozolomide and radiotherapy for newly diagnosed grade IV glioma
ChiCTR2400084456Phase 2Recruiting
- Sponsor
- Dongguan People's Hospital
- Start
- May 2024
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluoxetine and temozolomide in glioma, sponsored by Dongguan People's Hospital. Primary endpoint: Progression-free survival. Started May 2024; status: recruiting.
02
Drugs
fluoxetinetemozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on ChiCTR2400084456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084456.